Maria G. Castro, Ph.D.

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Gene Therapy, Glioma Therapy
Google:
"Maria Castro"
Mean distance: 18 (cluster 32)
 
Cross-listing:

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Geletu M, Taha Z, Arulanandam R, et al. (2019) Effect of Caveolin-1 upon Stat3-ptyr705 levels in breast and lung carcinoma cells. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
Núñez FJ, Mendez FM, Kadiyala P, et al. (2019) IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Science Translational Medicine. 11
Kadiyala P, Li D, Nunez FM, et al. (2019) High Density Lipoprotein-Mimicking Nanodiscs for Chemo-Immunotherapy against Glioblastoma Multiforme. Acs Nano
Núñez FJ, Mendez FM, Garcia-Fabiani MB, et al. (2019) Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures. Journal of Visualized Experiments : Jove
Haase S, Garcia-Fabiani MB, Carney S, et al. (2018) Mutant ATRX: uncovering a new therapeutic target for glioma. Expert Opinion On Therapeutic Targets
Yadav VN, Altshuler D, Kadiyala P, et al. (2018) Molecular Ablation of Tumor Blood Vessels Inhibits Therapeutic Effects of Radiation and Bevacizumab. Neuro-Oncology
Mendez FM, Núñez FJ, Zorrilla-Veloz RI, et al. (2018) Native Chromatin Immunoprecipitation Using Murine Brain Tumor Neurospheres. Journal of Visualized Experiments : Jove
Kamran N, Alghamri MS, Nunez FJ, et al. (2018) Current state and future prospects of immunotherapy for glioma. Immunotherapy. 10: 317-339
Kamran N, Li Y, Sierra M, et al. (2018) Melanoma induced immunosuppression is mediated by hematopoietic dysregulation. Oncoimmunology. 7: e1408750
Koschmann C, Farooqui Z, Kasaian K, et al. (2017) Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event. Npj Precision Oncology. 1: 32
See more...